Bausch Health Companies Inc.
6.16USD
-0.2700 (-4.20%)
Consensus EPS on the street’s adjusted basis, not the filed GAAP figure — which is why the actuals here can differ from the income statement.
| Period | Consensus EPS | 90 days ago | Revisions up (30d) | Revisions down (30d) |
|---|---|---|---|---|
| Current quarter | $1.19▼ | $1.24 | 1 | 2 |
| Next quarter | $1.27▼ | $1.29 | 0 | 3 |
| Current year | $4.47▲ | $4.33 | 2 | 1 |
| Next year | $4.19▲ | $4.06 | 1 | 2 |
Beat in 3 of the last 4
| Quarter | Estimate | Actual | Surprise |
|---|---|---|---|
| 2026-06-30 | $1.01 | $1.26 | +0.25 (+25.1%) |
| 2026-03-31 | $0.69 | $0.78 | +0.09 (+12.8%) |
| 2025-12-31 | $1.26 | $1.1 | -0.16 (-12.8%) |
| 2025-09-30 | $1.06 | $1.16 | +0.11 (+10.0%) |
75 ratings from 22 firms
Ratings are attributed to the research firm, not to individual analysts. See every ticker.
| Firm | Action | Rating | Price Target | Date |
|---|---|---|---|---|
| RBC Capital | Maintained | Sector Perform | $10 $9 | Apr 27, 2026 |
| Barclays | Maintained | Equal-Weight | $8 $7 | Feb 25, 2026 |
| Truist Securities | Maintained | Hold | $7 $8 | Jan 7, 2026 |
| Barclays | Initiated | Equal-Weight | $8 | Dec 9, 2025 |
| RBC Capital | Maintained | Sector Perform | $8.5 $10 | May 2, 2025 |
| Jefferies | Downgraded from Buy | Hold | $12 $8 | Feb 6, 2025 |
| RBC Capital | Maintained | Sector Perform | $11 $10 | Jan 30, 2025 |
| RBC Capital | Maintained | Sector Perform | $10 $11 | Nov 1, 2024 |
| RBC Capital | Maintained | Sector Perform | $10 $8.5 | Aug 2, 2024 |
| Piper Sandler | Downgraded from Neutral | Underweight | $9 $3 | Aug 2, 2024 |
| Truist Securities | Maintained | Hold | $8 $7 | Jul 25, 2024 |
| Raymond James | Initiated | Market Perform | $8 | Jul 10, 2024 |
| RBC Capital | Maintained | Sector Perform | $12 $11 | Apr 23, 2024 |
| RBC Capital | Reiterated | Sector Perform | $12 | Apr 12, 2024 |
| RBC Capital | Maintained | Sector Perform | $9 $12 | Apr 5, 2024 |
| RBC Capital | Maintained | Sector Perform | $8 $9 | Feb 23, 2024 |
| Jefferies | Upgraded from Hold | Buy | $9 $16 | Sep 20, 2023 |
| TD Cowen | Downgraded from Outperform | Market Perform | — | Jun 16, 2023 |
| Jefferies | Maintained | Buy | $7 $9.5 | May 22, 2023 |
| RBC Capital | Maintained | Sector Perform | $9 $8 | May 5, 2023 |
| Piper Sandler | Maintained | Neutral | $7 $6 | Sep 9, 2022 |
| RBC Capital | Maintained | Sector Perform | $4.5 $8 | Sep 1, 2022 |
| BMO Capital | Maintained | Market Perform | $15 $8 | Aug 10, 2022 |
| RBC Capital | Maintained | Sector Perform | $5 $4.5 | Aug 10, 2022 |
| RBC Capital | Downgraded from Outperform | Sector Perform | $12 $5 | Jul 29, 2022 |
70 filings from 19 insiders · 0 buy / 0 sell over 6m
Officers and directors of BHC, from the last two years of filings. Grants, gifts and option exercises are shown but not colour-coded — they are compensation, not a view on the price.
| Insider | Action | Shares | Price | Value | Date |
|---|---|---|---|---|---|
| LENAR AIMEE JOfficer | Sell | 36.8k | $7.03 | $259k | Aug 19, 2026 |
| LEUNG SANDRADirector | Grant | 6.8k | $4.93 | $34k | Jun 30, 2026 |
| PAULSON JOHN A.Director | Grant | 12.7k | $4.93 | $62k | Jun 30, 2026 |
| POWER ROBERT NDirector | Grant | 45.9k | — | — | May 22, 2026 |
| LEUNG SANDRADirector | Grant | 45.9k | — | — | May 22, 2026 |
| PAULSON JOHN A.Director | Grant | 45.9k | — | — | May 22, 2026 |
| KAVANAGH SARAH BALDWINDirector | Grant | 45.9k | — | — | May 22, 2026 |
| ROBERTS EIRY WYNDirector | Grant | 45.9k | — | — | May 22, 2026 |
| GOETTLER MICHAELDirector | Grant | 45.9k | — | — | May 22, 2026 |
| LEE FRANK DONDirector | Grant | 45.9k | — | — | May 22, 2026 |
| GARCIA CHRISTIAN ADirector | Grant | 45.9k | — | — | May 22, 2026 |
| WECHSLER AMY BDirector | Grant | 45.9k | — | — | May 22, 2026 |
| LEE FRANK DONDirector | Sell | 24.5k | $5.43 | $133k | May 19, 2026 |
| LEUNG SANDRADirector | Grant | 5.9k | $5.40 | $32k | Mar 31, 2026 |
| PAULSON JOHN A.Director | Grant | 11.6k | $5.40 | $63k | Mar 31, 2026 |
| WECHSLER AMY BDirector | Grant | 1.3k | $5.40 | $7k | Mar 31, 2026 |
| CARSON SEANA LYNNEGeneral Counsel | Sell | 11.3k | $5.77 | $65k | Mar 3, 2026 |
| CARSON SEANA LYNNEGeneral Counsel | Sell | 8.4k | $5.95 | $50k | Feb 27, 2026 |
| LEE STEVEN HYOSIGOfficer | Grant | 45.9k | — | — | Feb 25, 2026 |
| CARSON SEANA LYNNEGeneral Counsel | Grant | 212.3k | — | — | Feb 25, 2026 |
No analyst notes on BHC yet.
Analyst Ratings
5 analysts covering
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Consensus |
|---|---|---|---|---|---|---|
| Current | 0 | 0 | 7 | 0 | 0 | Hold3.00 |
| 1 mo ago | 0 | 0 | 7 | 0 | 0 | Hold3.00 |
| 2 mo ago | 0 | 0 | 7 | 0 | 0 | Hold3.00 |